ICD-10-CM Diagnosis Code T36.1X5S - Adverse effect of cephalosporins and other beta-lactam antibiotics, sequela (original) (raw)

ICD List Logo

ICD List 2025-2026 Edition

  1. Home
  2. ICD-10-CM Codes
  3. S00–T88
  4. T36-T50
  5. T36
  6. 2026 ICD-10-CM Code T36.1X5S

Adverse effect of cephalosporins and other beta-lactam antibiotics, sequela

ICD-10-CM Code:

T36.1X5S

ICD-10 Code for:

Advrs effect of cephalospor/oth beta-lactm antibiot, sequela

Is Billable?

Yes - Valid for Submission

Chronic Condition Indicator: [1]

Not chronic

Code Navigator:

T36.1X5S is a billable diagnosis code used to specify a medical diagnosis of adverse effect of cephalosporins and other beta-lactam antibiotics, sequela. The code is valid during the current fiscal year for the submission of HIPAA-covered transactions from October 01, 2025 through September 30, 2026. The code is exempt from present on admission (POA) reporting for inpatient admissions to general acute care hospitals.

This code describes a circumstance which influences the patient's health status but not a current illness or injury. The code is unacceptable as a principal diagnosis.

T36.1X5S is a sequela code, includes a 7th character and should be used for complications that arise as a direct result of a condition like adverse effect of cephalosporins and other beta-lactam antibiotics. According to ICD-10-CM Guidelines a "sequela" code should be used for chronic or residual conditions that are complications of an initial acute disease, illness or injury. The most common sequela is pain. Usually, two diagnosis codes are needed when reporting sequela. The first code describes the nature of the sequela while the second code describes the sequela or late effect.

  1. Code Information
  2. Approximate Synonyms
  3. Clinical Classification
  4. Clinical Information
  5. Coding Guidelines
  6. Tabular List of Diseases and Injuries
  7. Code Edits
  8. Diagnostic Related Groups Mapping
  9. Present on Admission (POA)
  10. Convert to ICD-9 Code
  11. Table of Drugs and Chemicals
  12. Patient Education
  13. Other Codes Used Similar Conditions
  14. Code History

The following list of clinical terms are approximate synonyms, alternative descriptions, or common phrases that might be used by patients, healthcare providers, or medical coders to describe the same condition. These synonyms and related diagnosis terms are often used when searching for an ICD-10 code, especially when the exact medical terminology is unclear. Whether you're looking for lay terms, similar diagnosis names, or common language alternatives, this list can help guide you to the correct ICD-10 classification.

Clinical Classifications group individual ICD-10-CM diagnosis codes into broader, clinically meaningful categories. These categories help simplify complex data by organizing related conditions under common clinical themes.

They are especially useful for data analysis, reporting, and clinical decision-making. Even when diagnosis codes differ, similar conditions can be grouped together based on their clinical relevance. Each category is assigned a unique CCSR code that represents a specific clinical concept, often tied to a body system or medical specialty.

CCSR Code: INJ075

Inpatient Default: X - Not applicable.

Outpatient Default: Y - Yes, default outpatient assignment for principal diagnosis or first-listed diagnosis.

a monocyclic beta-lactam antibiotic originally isolated from chromobacterium violaceum. it is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys. it may cause a superinfection with gram-positive organisms.

semisynthetic, broad-spectrum antibiotic derivative of cephalexin.

long-acting, broad-spectrum, water-soluble, cephalexin derivative.

semisynthetic wide-spectrum cephalosporin with prolonged action, probably due to beta-lactamase resistance. it is used also as the nafate.

orally active semisynthetic cephalosporin antibiotic with broad-spectrum activity.

a semisynthetic cephalosporin analog with broad-spectrum antibiotic action due to inhibition of bacterial cell wall synthesis. it attains high serum levels and is excreted quickly via the urine.

a third-generation cephalosporin antibiotic that is stable to hydrolysis by beta-lactamases.

a cephalosporin antibiotic that is administered intravenously or intramuscularly. it is active against most common gram-positive and gram-negative microorganisms, is a potent inhibitor of enterobacteriaceae, and is highly resistant to hydrolysis by beta-lactamases. the drug has a high rate of efficacy in many types of infection and to date no severe side effects have been noted.

a semisynthetic cephamycin antibiotic with a broad spectrum of activity against both gram-positive and gram-negative microorganisms. it has a high rate of efficacy in many types of infection and to date no severe side effects have been noted.

a second-generation cephalosporin administered intravenously or intramuscularly. its bactericidal action results from inhibition of cell wall synthesis. it is used for urinary tract infections, lower respiratory tract infections, and soft tissue and bone infections.

semisynthetic broad-spectrum cephalosporin with a tetrazolyl moiety that is resistant to beta-lactamase. it may be used to treat pseudomonas infections.

semisynthetic broad-spectrum cephalosporin.

a semisynthetic cephamycin antibiotic that is administered intravenously or intramuscularly. the drug is highly resistant to a broad spectrum of beta-lactamases and is active against a wide range of both aerobic and anaerobic gram-positive and gram-negative microorganisms.

one of the cephalosporins that has a broad spectrum of activity against both gram-positive and gram-negative microorganisms.

a semisynthetic cephamycin antibiotic resistant to beta-lactamase.

a pyridinium-substituted semisynthetic, broad-spectrum antibacterial used especially for pseudomonas infections in debilitated patients.

semisynthetic, broad-spectrum antibacterial derived from cephaloridine and used especially for pseudomonas and other gram-negative infections in debilitated patients.

a semisynthetic cephalosporin antibiotic which can be administered intravenously or by suppository. the drug is highly resistant to a broad spectrum of beta-lactamases and is active against a wide range of both aerobic and anaerobic gram-positive and gram-negative organisms. it has few side effects and is reported to be safe and effective in aged patients and in patients with hematologic disorders.

a broad-spectrum cephalosporin antibiotic and cefotaxime derivative with a very long half-life and high penetrability to meninges, eyes and inner ears.

broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. it has been proposed for infections with gram-negative and gram-positive organisms, gonorrhea, and haemophilus.

a semisynthetic cephalosporin antibiotic with antimicrobial activity similar to that of cephaloridine or cephalothin, but somewhat less potent. it is effective against both gram-positive and gram-negative organisms.

a cephalosporin antibiotic.

a cephalorsporin antibiotic.

a cephalosporin antibiotic.

a group of broad-spectrum antibiotics first isolated from the mediterranean fungus acremonium. they contain the beta-lactam moiety thia-azabicyclo-octenecarboxylic acid also called 7-aminocephalosporanic acid.

cephalosporin agents with excellent coverage against gram-positive cocci, such as staphylococcus and streptococcus. they have some activity against the gram-negative bacteria, but in general, gram-negative activity is decreased compared to 2nd, 3rd, and 4th generation cephalosporins.

agents with less activity against gram-positive cocci than first generation cephalosporins but have increased activity against gram-negative bacilli.

agents that are structurally similar to other cephalosporins but have a broader spectrum of activity against bacteria than the first and second generation cephalosporins. these agents cover more resistant streptococcus, staphylococcus, gram-positive anaerobes, and more resistant strains of haemophilus, neisseria, proteus, escherichia coli, and klebsiella (hnpek).

a cephalosporin antibiotic.

a semi-synthetic cephalosporin antibiotic.

a beta-lactam antibiotic produced by the actinobacterium streptomyces clavuligerus. it is a suicide inhibitor of bacterial beta-lactamase enzymes. administered alone, it has only weak antibacterial activity against most organisms, but given in combination with other beta-lactam antibiotics it prevents antibiotic inactivation by microbial lactamase.

acids, salts, and derivatives of clavulanic acid (c8h9o5n). they consist of those beta-lactam compounds that differ from penicillin in having the sulfur of the thiazolidine ring replaced by an oxygen. they have limited antibacterial action, but block bacterial beta-lactamase irreversibly, so that similar antibiotics are not broken down by the bacterial enzymes and therefore can exert their antibacterial effects.

When coding an adverse effect of a drug that has been correctly prescribed and properly administered, assign the appropriate code for the nature of the adverse effect followed by the appropriate code for the adverse effect of the drug.

The appropriate 7th character is to be added to each code from block Poisoning by, adverse effect of and underdosing of systemic antibiotics (T36). Use the following options for the aplicable episode of care:

The Medicare Code Editor (MCE) detects errors and inconsistencies in ICD-10-CM diagnosis coding that can affect Medicare claim validity. These Medicare code edits help medical coders and billing professionals determine when a diagnosis code is not appropriate as a principal diagnosis, does not meet coverage criteria. Use this list to verify whether a code is valid for Medicare billing and to avoid claim rejections or denials due to diagnosis coding issues.

There are selected codes that describe a circumstance which influences an individual's health status but not a current illness or injury, or codes that are not specific manifestations but may be due to an underlying cause. These codes are considered unacceptable as a principal diagnosis.

T36.1X5S is exempt from POA reporting - The Present on Admission (POA) indicator is used for diagnosis codes included in claims involving inpatient admissions to general acute care hospitals. POA indicators must be reported to CMS on each claim to facilitate the grouping of diagnoses codes into the proper Diagnostic Related Groups (DRG). CMS publishes a listing of specific diagnosis codes that are exempt from the POA reporting requirement. Review other POA exempt codes here.

CMS POA Indicator Options and Definitions

POA Indicator: Y

Reason: Diagnosis was present at time of inpatient admission.

CMS Pays CC/MCC DRG? YES

POA Indicator: N

Reason: Diagnosis was not present at time of inpatient admission.

CMS Pays CC/MCC DRG? NO

POA Indicator: U

Reason: Documentation insufficient to determine if the condition was present at the time of inpatient admission.

CMS Pays CC/MCC DRG? NO

POA Indicator: W

Reason: Clinically undetermined - unable to clinically determine whether the condition was present at the time of inpatient admission.

CMS Pays CC/MCC DRG? YES

POA Indicator: 1

Reason: Unreported/Not used - Exempt from POA reporting.

CMS Pays CC/MCC DRG? NO

Below are the ICD-9 codes that most closely match this ICD-10 code, based on the General Equivalence Mappings (GEMs). This ICD-10 to ICD-9 crosswalk tool is helpful for coders who need to reference legacy diagnosis codes for audits, historical claims, or approximate code comparisons.

ICD-9-CM: 909.5

Approximate Flag - The approximate mapping means this ICD-10 code does not have an exact ICD-9 equivalent. The matched code is the closest available option, but it may not fully capture the original diagnosis or clinical intent.

ICD-9-CM: E930.5

Approximate Flag - The approximate mapping means this ICD-10 code does not have an exact ICD-9 equivalent. The matched code is the closest available option, but it may not fully capture the original diagnosis or clinical intent.

The parent code T36.1X5 of the current diagnosis code is referenced in the Table of Drugs and Chemicals, this table contains a classification of drugs, industrial solvents, corrosive gases, noxious plants, pesticides, and other toxic agents.

According to ICD-10-CM coding guidelines it is advised to do not code directly from the Table of Drugs and Chemicals, instead always refer back to the Tabular List when doing the initial coding. Each substance in the table is assigned a code according to the poisoning classification and external causes of adverse effects. It is important to use as many codes as necessary to specify all reported drugs, medicinal or chemical substances. If the same diagnosis code describes the causative agent for more than one adverse reaction, poisoning, toxic effect or underdosing, utilize the code only once.

Filter table of drugs and chemicals:

Substance Poisoning Accidental (unintentional) Poisoning Accidental (self-harm) Poisoning Assault Poisoning Undetermined Adverse effect Underdosing
Aztreonam T36.1X1 T36.1X2 T36.1X3 T36.1X4 T36.1X5 T36.1X6
Cefacetrile T36.1X1 T36.1X2 T36.1X3 T36.1X4 T36.1X5 T36.1X6
Cefaclor T36.1X1 T36.1X2 T36.1X3 T36.1X4 T36.1X5 T36.1X6
Cefadroxil T36.1X1 T36.1X2 T36.1X3 T36.1X4 T36.1X5 T36.1X6
Cefalexin T36.1X1 T36.1X2 T36.1X3 T36.1X4 T36.1X5 T36.1X6
Cefaloglycin T36.1X1 T36.1X2 T36.1X3 T36.1X4 T36.1X5 T36.1X6
Cefaloridine T36.1X1 T36.1X2 T36.1X3 T36.1X4 T36.1X5 T36.1X6
Cefalosporins T36.1X1 T36.1X2 T36.1X3 T36.1X4 T36.1X5 T36.1X6
Cefalotin T36.1X1 T36.1X2 T36.1X3 T36.1X4 T36.1X5 T36.1X6
Cefamandole T36.1X1 T36.1X2 T36.1X3 T36.1X4 T36.1X5 T36.1X6
Cefamycin antibiotic T36.1X1 T36.1X2 T36.1X3 T36.1X4 T36.1X5 T36.1X6
Cefapirin T36.1X1 T36.1X2 T36.1X3 T36.1X4 T36.1X5 T36.1X6
Cefatrizine T36.1X1 T36.1X2 T36.1X3 T36.1X4 T36.1X5 T36.1X6
Cefazedone T36.1X1 T36.1X2 T36.1X3 T36.1X4 T36.1X5 T36.1X6
Cefazolin T36.1X1 T36.1X2 T36.1X3 T36.1X4 T36.1X5 T36.1X6
Cefbuperazone T36.1X1 T36.1X2 T36.1X3 T36.1X4 T36.1X5 T36.1X6
Cefetamet T36.1X1 T36.1X2 T36.1X3 T36.1X4 T36.1X5 T36.1X6
Cefixime T36.1X1 T36.1X2 T36.1X3 T36.1X4 T36.1X5 T36.1X6
Cefmenoxime T36.1X1 T36.1X2 T36.1X3 T36.1X4 T36.1X5 T36.1X6
Cefmetazole T36.1X1 T36.1X2 T36.1X3 T36.1X4 T36.1X5 T36.1X6
Cefminox T36.1X1 T36.1X2 T36.1X3 T36.1X4 T36.1X5 T36.1X6
Cefonicid T36.1X1 T36.1X2 T36.1X3 T36.1X4 T36.1X5 T36.1X6
Cefoperazone T36.1X1 T36.1X2 T36.1X3 T36.1X4 T36.1X5 T36.1X6
Ceforanide T36.1X1 T36.1X2 T36.1X3 T36.1X4 T36.1X5 T36.1X6
Cefotaxime T36.1X1 T36.1X2 T36.1X3 T36.1X4 T36.1X5 T36.1X6
Cefotetan T36.1X1 T36.1X2 T36.1X3 T36.1X4 T36.1X5 T36.1X6
Cefotiam T36.1X1 T36.1X2 T36.1X3 T36.1X4 T36.1X5 T36.1X6
Cefoxitin T36.1X1 T36.1X2 T36.1X3 T36.1X4 T36.1X5 T36.1X6
Cefpimizole T36.1X1 T36.1X2 T36.1X3 T36.1X4 T36.1X5 T36.1X6
Cefpiramide T36.1X1 T36.1X2 T36.1X3 T36.1X4 T36.1X5 T36.1X6
Cefradine T36.1X1 T36.1X2 T36.1X3 T36.1X4 T36.1X5 T36.1X6
Cefroxadine T36.1X1 T36.1X2 T36.1X3 T36.1X4 T36.1X5 T36.1X6
Cefsulodin T36.1X1 T36.1X2 T36.1X3 T36.1X4 T36.1X5 T36.1X6
Ceftazidime T36.1X1 T36.1X2 T36.1X3 T36.1X4 T36.1X5 T36.1X6
Cefteram T36.1X1 T36.1X2 T36.1X3 T36.1X4 T36.1X5 T36.1X6
Ceftezole T36.1X1 T36.1X2 T36.1X3 T36.1X4 T36.1X5 T36.1X6
Ceftizoxime T36.1X1 T36.1X2 T36.1X3 T36.1X4 T36.1X5 T36.1X6
Ceftriaxone T36.1X1 T36.1X2 T36.1X3 T36.1X4 T36.1X5 T36.1X6
Cefuroxime T36.1X1 T36.1X2 T36.1X3 T36.1X4 T36.1X5 T36.1X6
Cefuzonam T36.1X1 T36.1X2 T36.1X3 T36.1X4 T36.1X5 T36.1X6
Cephalexin T36.1X1 T36.1X2 T36.1X3 T36.1X4 T36.1X5 T36.1X6
Cephaloglycin T36.1X1 T36.1X2 T36.1X3 T36.1X4 T36.1X5 T36.1X6
Cephaloridine T36.1X1 T36.1X2 T36.1X3 T36.1X4 T36.1X5 T36.1X6
Cephalosporins T36.1X1 T36.1X2 T36.1X3 T36.1X4 T36.1X5 T36.1X6
Cephalosporins »N (adicillin) T36.1X1 T36.1X2 T36.1X3 T36.1X4 T36.1X5 T36.1X6
Cephalothin T36.1X1 T36.1X2 T36.1X3 T36.1X4 T36.1X5 T36.1X6
Cephalotin T36.1X1 T36.1X2 T36.1X3 T36.1X4 T36.1X5 T36.1X6
Cephradine T36.1X1 T36.1X2 T36.1X3 T36.1X4 T36.1X5 T36.1X6
Clavulanic acid T36.1X1 T36.1X2 T36.1X3 T36.1X4 T36.1X5 T36.1X6
Flomoxef T36.1X1 T36.1X2 T36.1X3 T36.1X4 T36.1X5 T36.1X6
Latamoxef T36.1X1 T36.1X2 T36.1X3 T36.1X4 T36.1X5 T36.1X6

Antibiotics

What are antibiotics?

Antibiotics are medicines that fight bacterial infections in people and animals. They work by killing the bacteria or by making it hard for the bacteria to grow and multiply.

Antibiotics can be taken in different ways:

What do antibiotics treat?

Antibiotics only treat certain bacterial infections, such as strep throat, urinary tract infections, and E. coli.

You may not need to take antibiotics for some bacterial infections. For example, you might not need them for many sinus infections or some ear infections. Taking antibiotics when they're not needed won't help you, and they can have side effects. Your health care provider can decide the best treatment for you when you're sick. Don't ask your provider to prescribe an antibiotic for you.

Do antibiotics treat viral infections?

Antibiotics do not work on viral infections. For example, you shouldn't take antibiotics for:

What are the side effects of antibiotics?

The side effects of antibiotics range from minor to very severe. Some of the common side effects include:

More serious side effects can include:

Call your health care provider if you develop any side effects while taking your antibiotic.

Why is it important to take antibiotics only when they're needed?

You should only take antibiotics when they are needed because they can cause side effects and can contribute to antibiotic resistance. Antibiotic resistance happens when the bacteria change and become able to resist the effects of an antibiotic. This means that the bacteria continue to grow.

How do I use antibiotics correctly?

When you take antibiotics, it is important that you take them responsibly:

Centers for Disease Control and Prevention

[Learn More in MedlinePlus]

Drug Reactions

Most of the time, medicines make our lives better. They reduce aches and pains, fight infections, and control problems such as high blood pressure or diabetes. But medicines can also cause unwanted reactions, such as drug interactions, side effects, and allergies.

What is a drug interaction?

A drug interaction is a change in the way a drug acts in the body when taken with certain other drugs, foods, or supplements or when taken while you have certain medical conditions. Examples include:

Interactions could cause a drug to be more or less effective, cause side effects, or change the way one or both drugs work.

What are side effects?

Side effects are unwanted, usually unpleasant, effects caused by medicines. Most are mild, such as a stomachache, dry mouth, or drowsiness, and go away after you stop taking the medicine. Others can be more serious. Sometimes a drug can interact with a disease that you have and cause a side effect. For example, if you have a heart condition, certain decongestants can cause you to have a rapid heartbeat.

What are drug allergies?

Drug allergies are another type of reaction. They can range from mild to life-threatening. Skin reactions, such as hives and rashes, are the most common type. Anaphylaxis, a serious allergic reaction, is less common.

How can I stay safe when taking medicines?

When you start a new prescription or over-the-counter medicine, make sure you understand how to take it correctly. Know which other medicines, foods, and supplements you need to avoid. Always talk to your health care provider or pharmacist if you have questions about your medicines.

[Learn More in MedlinePlus]